Company: HRTX
Filing Date: 2025-06-18
Form Type: 8-K
Source: 0000950170-25-087555
Chunk: 0

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-06-18
Form: 8-K
Item: Item 5.07
Chunk 0
---
Item 5.07 Submission of Matters to a Vote of Security Holders.

At the 2025 Annual Meeting of Stockholders (the “ Annual Meeting”) of Heron Therapeutics, Inc. (the “Company”) held on June 12, 2025, the Company’s stockholders voted on four proposals, including: (1) to elect six director nominees: Craig Collard, Sharmila Dissanaike, M. D., FACS, FCCM, Craig Johnson, Michael Kaseta, Adam Morgan, and Christian Waage to serve until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal; (2) to ratify the appointment of Withum Smith+Brown, PC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025; (3) to approve, on a nonbinding advisory basis, compensation paid to the Company’s Named Executive Officers during the fiscal year ended December 31, 2024; and (4) to approve, on a nonbinding advisory basis, the frequency of future advisory votes on the compensation paid to the Company’s Named Executive Officers.

Only stockholders of record as of the close of business on April 15, 2025 (the “Record Date”) were entitled to vote at the Annual Meeting. As of the Record Date, 152,530,696 shares of common stock of the Company were outstanding and entitled to vote at the Annual Meeting. At the Annual Meeting, 120,003,504 shares of common stock of the Company were represented in person and by proxy, constituting a quorum for the Annual Meeting..

The votes with respect to each of the four proposals voted on at the Annual Meeting are set forth below:

Proposal 1: The Company’s stockholders elected the six director nominees to serve until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal:

  Name of Director Nominee             For        Against      Abstain          Broker  
                                                                                        
                                                                             Non-Votes  
 ────────────────────────────────────────────────────────────────────────────────────────
  Mr. Collard                   82,777,195      1,274,608       47,119      35,904,582  
  Dr. Dissanaike                81,364,822      2,625,421      108,679